Dr. Betty Tyler is an Assistant Professor of Neurosurgery at Johns Hopkins University. She runs a highly successful and productive laboratory and has a national reputation for stellar science in the field of translational research and local delivery of chemotherapeutic agents for brain tumor therapy. Dr. Tyler assisted in the preclinical studies that led to bringing Gliadel to brain tumor patients as a standard of care, and also evaluated the efficacy of the local delivery of Paclitaxel from a novel thermal gel depot through commercial funding. The data in these studies were the scientific bases of a multi-institutional Phase I clinical trial for patients with malignant glioma.
Dr. Tyler’s collaborative efforts with scientists within Johns Hopkins as well as with researchers throughout the United States have led to multiple scientific breakthroughs. In addition to publishing over 85 peer-reviewed articles she has mentored and taught over 250 neurosurgical residents, medical students, and undergraduate students in research design, surgical techniques and statistical analysis.
She directs her work toward therapeutic progress, and mentoring new scientists, with the goal of bringing effective therapies to patients with brain tumors and making a difference in the brain cancer research field.